{'fraction_non_alphanumeric': 0.026004728132387706, 'fraction_numerical': 0.00591016548463357, 'mean_word_length': 5.8861788617886175, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Binding studies on two functional cardioselective antimuscarinic compounds

Abstract— Vecuronium and himbacine are antimuscarinic compounds which in functional studies exhibited a ca 6‐ and 10‐fold higher potency at cardiac muscarininc receptors than at ileal muscarininc receptors. However in binding studies both compounds failed to differentiate between [3H](−)‐QNB binding sites in guinea‐pig atrial and ileal muscle homogenates. In the latter experiments, the dissociation constants of vecuronium in atria and ileum and that of himbacine in ileum were lower than the values determined functionally. The basis for the lack of cardioselectivity in binding studies is not known. These compounds add to the list of functional cardioselective muscarinic receptor antagonists that failed to display selectivity in binding studies with [3H](−)‐QNB.